Molecular imaging/nuclear medicine professionals explore new research in fight against diseases

SNM's 53rd Annual Meeting June 37 in San Diego hosts largest attendance of molecular imaging and nuclear medicine physicians, technologists, scientists, physicists and pharmacists

Leading molecular imaging and nuclear medicine authorities will address more than 4,000 physicians, technologists, scientists and pharmacists about future directions and the latest medical research results during SNM's 53rd Annual Meeting June 37 at the San Diego Convention Center.

"We know that molecular imaging and nuclear medicine will lead to a much greater ability to characterize diseases, diagnose them at a very early stage, treat them effectively and monitor the effectiveness of such treatment," said SNM President Peter S. Conti, M.D., Ph.D., who is professor of radiology, clinical pharmacy and biomedical engineering at the University of Southern California, Los Angeles, and director of the PET Imaging Science Center at USC's Keck School of Medicine. "Molecular imaging and nuclear medicine research have a proven record of leading to improvements in the diagnosis and treatment of life-threatening cancer, heart and other diseases that affect millions each year," noted Conti, speaking on behalf of the society, which has more than 16,000 physician, technologist and scientist members in 78 countries. "Medical practitioners, technologists, scientists, physicists and pharmacists from around the world come to this premier event for molecular imaging and nuclear medicine educational opportunities," he explained, adding, "This meeting brings together the best and brightest."

"SNM's Annual Meeting is the place for all practitioners of molecular imaging and nuclear medicine to find high-quality resources, education, products and services to help them meet the demands of this cutting-edge medical profession," noted SNM Technologist Section President Valerie R. Cronin, CNMT, FSNMTS, director of imaging services in the Catholic Health System of Western New York in Buffalo, N.Y. This year, SNM and the SNM Technologist Section will present about 100 continuing education courses focusing on molecular imaging in clinical practice, PET/CT, brain imaging, pediatrics, oncology and therapy, thyroid cancer, cardiovascular nuclear medicine, radiation safety, molecular and clinical brain imaging, she added. Typically, more than 1,600 scientific, technologist and technologist-student abstracts are presented featuring the latest research in the molecular imaging and nuclear medicine profession. This year, one session will provide a look at events in Chernobyl in the former USSR (now the Ukraine) on the 20th anniversary of that city's nuclear power accident.

Full-day categorical seminars for physicians, technologists and scientists will be presented on June 3. Topics include "Diagnosis and Management of Breast Cancer: Current Practice and New Frontiers," "Biomarkers in Central Nervous System," "Molecular Imaging and Therapy and the NIH Roadmap: Perspectives and Potential," "PET/CT in Oncology: Focus on the Referring Physician: What Does Your Referring Physician Want From PET/CT?" "PET/CT Scanners: What's Available and How They Work," "Expanding the Use of Nuclear Cardiology: Advances in Radionuclide Imaging and Integration With Other Developing Image Modalities," "Pediatric Oncology: From Bench to Bedside and Beyond," "New Horizons in Oncology and Neurology," "Opportunities and Challenges in Modern Medicine Technology," "PET/CT: An Atlas in Application in Technology" and "Cardiology: A Comprehensive Look at Nuclear Medicine Today."

Several new events will be featured this year. Members from the German Society of Nuclear Medicine and other selection organizations have been invited to present teaching posters. Attendees will be able to test knowledge in reading and interpreting actual cases with "Case of the Day" posters, and basic science "summary sessions" will highlight the most important science presented in the radiopharmaceutical chemistry and instrumentation and data analysis tracks.

Educational exhibit posters are designed to teach or review common molecular imaging and nuclear medicine/PET findings, pathologic correlations, procedures, techniques, treatments and interventions. Authors of educational exhibits typically present a series of techniques that help teach problem-solving skills, pattern recognition, imaging skills or the use of correlative imaging. And, in order to foster high-quality research by young professionals, the SNM Young Professionals Committee of the Academic Council, in conjunction with SNM, co-sponsors an annual competition for the best research-based presentation on basic science or clinical topics.

To register for the conference, visit the SNM Web site at


About SNM
SNM is holding its 53rd Annual Meeting June 37 at the San Diego Convention Center. Research topics for the 2006 meeting include molecular imaging in clinical practice in the fight against cancer; the role of diagnostic imaging in the management of metastatic bone disease, metabolic imaging for heart disease, neuroendocrine and brain imaging, new agents for imaging infection and inflammation, and an examination of dementia, neurodegeneration, movement disorders and thyroid cancer.

SNM is an international scientific and professional organization of more than 16,000 members dedicated to promoting the science, technology and practical applications of molecular and nuclear imaging to diagnose, manage and treat diseases in women, men and children. Founded more than 50 years ago, SNM continues to train physicians, technologists, scientists, physicists, chemists and radiopharmacists in state-of-the-art imaging procedures and advances; provide essential resources for health care practitioners and patients; publish the most prominent peer-reviewed resource in the field; sponsor research grants, fellowships and awards; and host the premier annual meeting for medical imaging. SNM members have introduced--and continue to explore--biological and technological innovations in medicine that noninvasively investigate the molecular basis of diseases, benefiting countless generations of patients. SNM is based in Reston, Va.; additional information can be found online at

Last reviewed: By John M. Grohol, Psy.D. on 30 Apr 2016
    Published on All rights reserved.